FDA CLEARS 53 NMEs IN 1996 -- AVERAGE APPROVAL TIME IS 20.5; NEUROPHARM DRUGS APPEAR READY FOR 1997 CLEARANCE: THREE PARKINSON's THERAPIES POISED FOR APPROVAL
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
